TTOO Historical Cash Flow
| TTOO Stock | USD 0.26 0.02 7.14% |
Analysis of T2 Biosystms cash flow over time is an excellent tool to project T2 Biosystms future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 1.7 M or Capital Expenditures of 164.2 K as it is a great indicator of T2 Biosystms ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining T2 Biosystms latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether T2 Biosystms is a good buy for the upcoming year.
TTOO |
About TTOO Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in TTOO balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which TTOO's non-liquid assets can be easily converted into cash.
T2 Biosystms Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by T2 Biosystms to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of T2 Biosystms operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from T2 Biosystms' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.At this time, T2 Biosystms' Change To Account Receivables is very stable compared to the past year. As of the 19th of January 2025, Other Cashflows From Investing Activities is likely to grow to about 12.1 M, while Stock Based Compensation is likely to drop about 4.9 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Other Non Cash Items | 3.1M | 773K | 889.0K | 1.7M | Depreciation | 2.3M | 859K | 987.9K | 938.5K |
T2 Biosystms cash flow statement Correlations
Click cells to compare fundamentals
T2 Biosystms Account Relationship Matchups
High Positive Relationship
High Negative Relationship
T2 Biosystms cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 6.1M | 6.5M | (11.9M) | 4.4M | 3.9M | 4.1M | |
| Stock Based Compensation | 3.9M | 7.1M | 6.5M | 4.4M | 5.0M | 4.9M | |
| Free Cash Flow | (44.0M) | (39.3M) | (51.0M) | (48.3M) | (43.5M) | (45.7M) | |
| Change In Working Capital | (6.5M) | (2.2M) | (503K) | (4.0M) | (3.6M) | (3.5M) | |
| Begin Period Cash Flow | 11.2M | 17.3M | 23.8M | 11.9M | 10.7M | 10.2M | |
| Other Cashflows From Financing Activities | 296K | 567K | (108K) | (43K) | (38.7K) | (36.8K) | |
| Depreciation | 3.2M | 2.5M | 2.3M | 859K | 987.9K | 938.5K | |
| Other Non Cash Items | 3.3M | 3.9M | 3.1M | 773K | 889.0K | 1.7M | |
| Capital Expenditures | 804K | 460K | 339K | 192K | 172.8K | 164.2K | |
| Total Cash From Operating Activities | (43.2M) | (38.9M) | (50.6M) | (48.1M) | (43.3M) | (45.5M) | |
| Net Income | (46.8M) | (49.2M) | (62.0M) | (50.1M) | (45.1M) | (47.3M) | |
| Total Cash From Financing Activities | 85.6M | 20.5M | 29.1M | 52.7M | 60.6M | 43.7M | |
| End Period Cash Flow | 17.3M | 23.8M | 11.9M | 16.2M | 14.6M | 28.9M | |
| Change To Inventory | 441K | (1.9M) | (949K) | (744K) | (669.6K) | (703.1K) | |
| Total Cashflows From Investing Activities | (593K) | (761K) | (36.3M) | 24.8M | 28.5M | 29.9M | |
| Change To Account Receivables | (2.3M) | (35K) | 3.0M | 743K | 854.5K | 897.2K | |
| Change To Netincome | 12.5M | 8.1M | 7.0M | 10M | 11.5M | 8.1M | |
| Investments | (35.5M) | 25.3M | 9.7M | (202K) | (232.3K) | (243.9K) | |
| Issuance Of Capital Stock | 85.3M | 20.0M | 29.5M | 53.0M | 60.9M | 45.0M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.